Expert panelists share their perspectives on best strategies to risk stratify patients diagnosed with cutaneous squamous cell carcinoma.
Pellini Discusses Immunotherapies and Current Limitations of ctDNA in Perioperative NSCLC
Community Oncologists on the Importance of Self-Reliance and Collegial Trust as Women in Medicine
Florida Cancer Specialists & Research Institute Calls for Reform in Value-Based Oncology Care Programming
Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers
Immunogenomics Demonstrate Predictive Capability to Immunotherapy Resistance in Uveal Melanoma
Florida Cancer Specialists & Research Institute Clinical Research Driving Progress to Cure Cancer
Dr Liu Previews ASCO 2024 Lung Cancer Data
Dr Rajkumar Previews ASCO 2024 Data in Multiple Myeloma
Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer
Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer